ÑÊÀ×ÀÒÜ (8.52 Êá â àðõèâå, ôîðìàò MS Word)

"Ðûíîê ÁÀÄ" ¹7(81) íîÿáðü/äåêàáðü, 2013

ÏÐÈ ÏÓÁËÈÊÀÖÈÈ ÌÀÒÅÐÈÀËΠÑÑÛËÊÀ ÍÀ ÈÑÒÎ×ÍÈÊ ÎÁßÇÀÒÅËÜÍÀ !!!

ÏÎÄÏÈÑÊÀ ÍÀ ÆÓÐÍÀË

50 òîðãîâûõ íàèìåíîâàíèé ëåêàðñòâåííûõ ïðåïàðàòîâ - ëèäåðîâ çà Ñåíòÿáðü 2013 ãîäà ïî Ðîññèè

Ðåéòèíã ïîñòðîåí ïî ñòîèìîñòíûì ïîêàçàòåëÿì îáúåìîâ ïðîäàæ ïî äàííûì ðîçíè÷íîãî àóäèòà çà ñåíòÿáðü 2013 ãîäà. Ìàðêåòèíãîâîå àãåíòñòâî DSM Group.

Òîðãîâîå íàèìåíîâàíèå ïðåïàðàòà

Ïðîèçâîäèòåëü

Ìåñòî

â ðåéòèíãå

Èçìåíåíèå ê ïðîøëîìó ìåñÿöó

ÀÐÁÈÄÎË

ÔÀÐÌÑÒÀÍÄÀÐÒ ÎÎÎ

1

+16

ÒÅÐÀÔËÞ

ðàçíûå

2

+10

ÊÀÃÎÖÅË

ÍÈÀÐÌÅÄÈÊ ÏËÞÑ ÎÎÎ

3

+15

ÝÑÑÅÍÖÈÀËÅ

SANOFI-AVENTIS

4

-3

ÀÍÀÔÅÐÎÍ

ÌÀÒÅÐÈÀ ÌÅÄÈÊÀ

5

+33

ÎÖÈËËÎÊÎÊÖÈÍÓÌ

LABORATOIRES BOIRON

6

+31

ËÀÇÎËÂÀÍ

BOEHRINGER INGELHEIM

7

+36

ÀÖÖ

ðàçíûå

8

+21

ÈÍÃÀÂÈÐÈÍ

ÂÀËÅÍÒÀ ÎÀÎ

9

+56

ÊÎÍÊÎÐ

NYCOMED

10

-7

ÍÓÐÎÔÅÍ

ðàçíûå

11

-6

ËÈÍÅÊÑ

LEK D.D.

12

-2

ÍÀÉÇ

DR.REDDY'S LABORATORIES LTD

13

-6

ÀÊÒÎÂÅÃÈÍ

NYCOMED

14

-10

ÑÒÐÅÏÑÈËÑ

ðàçíûå

15

+38

ÂÈÀÃÐÀ

PFIZER

16

-10

ÊÎËÄÐÅÊÑ

GLAXOSMITHKLINE TRADING

17

+71

ÀËÔËÓÒÎÏ

BIOTEHNOS S.A.

18

-9

ÍÎ-ØÏÀ

SANOFI-AVENTIS

19

-4

ÏÅÍÒÀËÃÈÍ

ÔÀÐÌÑÒÀÍÄÀÐÒ ÎÀÎ

20

-12

ÝÊÇÎÄÅÐÈË

ðàçíûå

21

-19

ÑÓÌÀÌÅÄ

PLIVA HRVATSKA D.O.O.

22

+13

ÊÀÐÄÈÎÌÀÃÍÈË

NYCOMED

23

-9

ËÎÇÀÏ

ZENTIVA A.S.

24

-8

ÒÈÇÈÍ

ðàçíûå

25

-14

ÀÌÈÊÑÈÍ

ðàçíûå

26

+63

ÌÀÃÍÅ

SANOFI-AVENTIS

27

+15

ÂÈÔÅÐÎÍ

ÔÅÐÎÍ ÎÎÎ

28

+12

ÌÅÊÑÈÄÎË

ðàçíûå

29

-9

ËÈÐÈÊÀ

PFIZER

30

-11

ÄÅÒÐÀËÅÊÑ

SERVIER

31

-18

ÎÒÐÈÂÈÍ

NOVARTIS

32

+39

ÂÈÒÐÓÌ

UNIPHARM INC

33

+15

ÂÎËÜÒÀÐÅÍ

ðàçíûå

34

-4

ÀÍÒÈÃÐÈÏÏÈÍ

NATUR PRODUKT

35

-

ÒÀÍÒÓÌ

CSC LTD

36

+23

ÝÐÅÑÏÀË

SERVIER

37

+50

ÑÈÀËÈÑ

ELI LILLY

38

-15

ÌÎÂÀËÈÑ

ðàçíûå

39

-18

ÀÌÎÊÑÈÊËÀÂ

LEK D.D.

40

+7

ÒÅÐÀÔËÅÊÑ

SAGMEL INC

41

ÌÈËÜÃÀÌÌÀ

WOERWAG PHARMA GMBH & CO.KG

42

-15

ÃÅÏÒÐÀË

ABBOTT GMBH & CO.KG

43

-17

ÊÅÒÎÍÀË

LEK D.D.

44

-8

ÌÅÇÈÌ ÔÎÐÒÅ

A.MENARINI PHARMACEUTICAL INDUSTRY'S GROUP LTD

45

-20

ÄÞÔÀÑÒÎÍ

SOLVAY PHARMACEUTICALS B.V.

46

-22

ÝÍÀÏ

KRKA

47

-1

ÎÌÅÇ

DR.REDDY'S LABORATORIES LTD

48

+3

ÃÅÊÑÎÐÀË

ðàçíûå

49

-17

ÒÐÎÊÑÅÂÀÇÈÍ

ACTAVIS GROUP HF.

50

-28